PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor - PubMed (original) (raw)

PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor

S H Green et al. J Cell Biol. 1986 Mar.

Abstract

Four mutant PC12 pheochromocytoma cell lines that are nerve growth factor (NGF)-nonresponsive (PC12nnr) have been selected from chemically mutagenized cultures by a double selection procedure: failure both to grow neurites in the presence of NGF and to survive in NGF-supplemented serum-free medium. The PC12nnr cells were deficient in all additional NGF responses surveyed: abatement of cell proliferation, changes in glycoprotein composition, induction of ornithine decarboxylase, rapid changes in protein phosphorylation, and cell surface ruffling. However, PC12nnr cells closely resembled non-NGF-treated PC12 cells in most properties tested: cell size and shape; division rate; protein, phosphoprotein, and glycoprotein composition; and cell surface morphology. All four PC12nnr lines differed from PC12 cells in three ways in addition to failure of NGF response: PC12nnr cells failed to internalize bound NGF by the normal, saturable, high-affinity mechanism present in PC12 cells. The PC12nnr cells bound NGF but entirely, or nearly entirely, at low-affinity sites only, whereas PC12 cells possess both high- and low-affinity NGF binding sites. The responses to dibutyryl cyclic AMP that were tested appeared to be enhanced or altered in the PC12nnr cells compared to PC12 cells. Internalization of, and responses to, epidermal growth factor were normal in the PC12nnr cells ruling out a generalized defect in hormonal binding, uptake, or response mechanisms. These findings are consistent with a causal association between the presence of high-affinity NGF receptors and of NGF responsiveness and internalization. A possible relationship is also suggested between regulation of cAMP responses and regulation of NGF responses or NGF receptor affinity.

PubMed Disclaimer

Cited by

Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.
Cazorla M, Arrang JM, Prémont J. Cazorla M, et al. Br J Pharmacol. 2011 Feb;162(4):947-60. doi: 10.1111/j.1476-5381.2010.01094.x. Br J Pharmacol. 2011. PMID: 21039416 Free PMC article.
Inhibition of RhoA GTPase and the subsequent activation of PTP1B protects cultured hippocampal neurons against amyloid β toxicity.
Chacon PJ, Garcia-Mejias R, Rodriguez-Tebar A. Chacon PJ, et al. Mol Neurodegener. 2011 Feb 4;6(1):14. doi: 10.1186/1750-1326-6-14. Mol Neurodegener. 2011. PMID: 21294893 Free PMC article.
Regulation of nerve growth factor receptor gene expression by nerve growth factor in the developing peripheral nervous system.
Miller FD, Mathew TC, Toma JG. Miller FD, et al. J Cell Biol. 1991 Jan;112(2):303-12. doi: 10.1083/jcb.112.2.303. J Cell Biol. 1991. PMID: 1671048 Free PMC article.
A comparison of nerve growth factor binding protocols with native and mutant PC12 cells.
Kasaian MT, Neet KE. Kasaian MT, et al. Neurochem Res. 1990 Dec;15(12):1167-74. doi: 10.1007/BF01208576. Neurochem Res. 1990. PMID: 1965856
Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkC.
Weinkauf C, Pereiraperrin M. Weinkauf C, et al. Infect Immun. 2009 Apr;77(4):1368-75. doi: 10.1128/IAI.01450-08. Epub 2009 Jan 29. Infect Immun. 2009. PMID: 19179422 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1269-73 - PubMed
1. Science. 1985 Jan 11;227(4683):140-6 - PubMed
1. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4055-8 - PubMed
1. Proc Natl Acad Sci U S A. 1984 Nov;81(21):6681-5 - PubMed
1. J Biol Chem. 1983 Mar 10;258(5):3370-5 - PubMed

PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor - PubMed (original) (raw)